Definium Therapeutics (DFTX) Change in Acquisitions & Divestments (2025 - 2026)
Definium Therapeutics' (DFTX) quarterly Change in Acquisitions & Divestments came in at $42.0 million in Q1 2026, up 2.44% on a QoQ basis from $41.0 million in Q4 2025.
Definium Therapeutics (DFTX) Change in Acquisitions & Divestments (2025 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has 2 years of Change in Acquisitions & Divestments data on file, last reported at $42.0 million in Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $42.0 million in Q1 2026; TTM through Mar 2026 was $158.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $116.8 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $42.0 million, up from $41.0 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for DFTX reached as high as $42.0 million in Q3 2025 and fell as low as $33.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Definium Therapeutics | 4.47 Bn | 4.47 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.00 Mn |
| Mar 31, 2026 | 42.00 Mn |
| Dec 31, 2025 | 41.00 Mn |
| Dec 31, 2025 | 41.00 Mn |
| Sep 30, 2025 | 42.00 Mn |
| Sep 30, 2025 | 42.00 Mn |
| Jun 30, 2025 | 33.75 Mn |
| Jun 30, 2025 | 33.75 Mn |